Breast Implants and Reconstructive Devices | Market Insights | US | 2024
The breast implant and reconstructive device market in the US is expected to experience modest growth over the forecast period, driven by factors such as a high aesthetic consciousness in the country, increasing awareness of the availability and benefits of breast reconstruction, and advancements in technologies. However, the market is also hindered by ongoing safety concerns related to breast implants and the potential for adverse events, such as capsular contracture and BIA-ALCL. To mitigate these risks, manufacturers are investing in product development to improve implant safety and efficacy, as well as assessing both existing and emerging products in clinical studies; the FDA is also increasing oversight of breast implants and reconstructive devices to ensure patient safety.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for breast implants and reconstructive devices in the US from 2019 through 2032.
